3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
12
Lymphoma, B-Cell
10
Recurrence
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, Non-Hodgkin
8
Multiple Myeloma
5
Lymphoma, Mantle-Cell
5
Burkitt Lymphoma
5
Lymphoma, Follicular
4
Lymphoma
4
Neoplasms
3
Neoplasm, Residual
3
Leukemia, Myeloid, Acute
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Lymphoma, B-Cell, Marginal Zone
2
Breast Neoplasms
2
Solid Tumors
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Pyloric Stenosis, Hypertrophic
1
Platinum-Resistant Ovarian Carcinoma
1
Plasmacytoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Nasopharyngeal Carcinoma
1
Mesothelioma, Malignant
1
Meningeal Carcinomatosis
1
Interventions
pembrolizumab
137
Nivolumab
116
Ipilimumab
68
Cyclophosphamide
33
Specimen Handling
31
Magnetic Resonance Spectroscopy
28
trametinib
23
binimetinib
22
fludarabine
21
Interleukin-2
20
dabrafenib
19
relatlimab
17
encorafenib
17
Biopsy
17
CTLA-4 Antigen
16
cemiplimab
15
atezolizumab
15
aldesleukin
15
Radiosurgery
15
fludarabine phosphate
14
Opdualag
14
Radiotherapy
11
lenvatinib
10
Blood Specimen Collection
10
lifileucel
9
Paclitaxel
8
Cisplatin
8
Bevacizumab
8
spartalizumab
7
cobimetinib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Immunotherapy, Adoptive
×
1 year
×
Clear all
No trials found.